Icosavax is a startup based in the United States, 1 tracked investor.
Icosavax is a startup founded in 2015 based in the United States. Brouky records 1 investor associated with the company.
Icosavax develops virus-like particle vaccines designed to protect against infectious diseases by mimicking natural viruses to stimulate immune responses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.